Novel therapies for the treatment of inflammatory airway disease. - Wikidata - awgldk - TriplyDB

Novel therapies for the treatment of inflammatory airway disease.

Novel therapies for the treatment of inflammatory airway disease.

http://www.wikidata.org/entity/Q35040779

about

COPD: the patient perspective Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).Increased expression of Siglec-9 in chronic obstructive pulmonary disease.Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.

P2860

Q26764894-962F9FC0-E285-4055-86D3-23819FE9D9DD Q28391885-707DAB4B-1857-48BF-81DA-139320FD8D21 Q35987189-D03F266C-E2CC-4D9E-830C-8147C4F5DC7C Q37147437-53CBB55C-81A0-4F5A-ACA5-C810F2636E93 Q37814698-7BA6CF9C-9F18-4E11-B70C-DA26BF5753C3 Q40071781-18521105-7E2C-4D99-B67B-79F01865CA5E Q46417491-79399868-F658-4FF2-ADE0-12FC97722272

P2860

Novel therapies for the treatment of inflammatory airway disease.

http://www.wikidata.org/entity/Q35040779

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Novel therapies for the treatment of inflammatory airway disease.

@ast

Novel therapies for the treatment of inflammatory airway disease.

@en

type

label

Novel therapies for the treatment of inflammatory airway disease.

@ast

Novel therapies for the treatment of inflammatory airway disease.

@en

prefLabel

Novel therapies for the treatment of inflammatory airway disease.

@ast

Novel therapies for the treatment of inflammatory airway disease.

@en

P1433

Q35040779-84C696FB-7DBA-4FDA-81F9-3C09A128AD04

P1476

Q35040779-FF1D73E7-C8CC-415A-8281-B7C0445730A9

P2093

Q35040779-4C62CAF3-6FE7-496E-B157-FA71ADFF141E

Q35040779-8C2608D6-63BB-46AD-AF95-8DE255F8ACAC

P2860

Q35040779-0442BC09-9A10-4065-850B-A6087F551258

Q35040779-0B2DE6E6-65E3-4E13-AF58-B37B94F6B2CE

Q35040779-10F6E06D-1BB5-4169-BAF8-33F2A05B5270

Q35040779-11E6890E-9F0F-4D1D-930D-990B462812F4

Q35040779-12220574-1D82-44BF-A0CA-3B7B087BCB90

Q35040779-219611B0-3262-4398-8669-C888CD5E2F9B

Q35040779-28274DB5-BC46-4CF5-B05A-FC166F748D05

Q35040779-3204EAB7-E129-4F70-A691-BE3423E526FE

Q35040779-359D80AD-6CB7-432E-9FBB-0FA1BF6FBC52

Q35040779-36063AF8-5310-4797-BBAC-AEF5FD11C219

P304

Q35040779-F008EFE8-6D99-43CE-AF81-70EDC3FCED92

P31

Q35040779-9A2F64C2-FA5D-4DD8-BD25-659DCD3CCF4B

P356

Q35040779-786E3EEA-0E41-4EA1-97EF-21AEF5FDD0EB

P407

Q35040779-54D3D21D-5C16-437C-A466-15F1C9E5F673

P433

Q35040779-FEA74DCD-E5D0-4C01-898E-3E8E47E89179

P478

Q35040779-62410741-09BE-4195-88F9-31BFD5F58F4A

P577

Q35040779-7D32BAFC-BB21-4F1D-9EC7-148A57E1340F

P698

Q35040779-286B6D24-796C-4B43-B394-D7732F8B2A29

P356

13543784.12.1.5

P1433

Expert Opinion on Investigational Drugs

P1476

Novel therapies for the treatment of inflammatory airway disease.

@en

P2093

David J Hele

http://www.w3.org/2001/XMLSchema#string

Maria G Belvisi

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor-alpha converting enzyme

Role of p38 MAP kinase in LPS-induced airway inflammation in the rat

Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

The role of leukotrienes in upper and lower airway inflammation and the implications for treatment.

The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands.

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.

Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.

Recent advances: Respiratory medicine.

P304

5-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.12.1.5

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12517250

http://www.w3.org/2001/XMLSchema#string